Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler’s Syndrome

Marko BAREŠIĆ, Joško MITROVIĆ, Jadranka MOROVIĆ VERGLES, Branimir ANIĆ

DOI: 10.5606/ArchRheumatol.2016.6000

Issue: Volume 31 - Issue 4 - December 2016
6459 4584

Prevalence of Mediterranean FeVer Gene Mutations in Turkish Cypriot Population

Nilüfer GALİP, Ceyhun DALKAN, Ayşe TERALI, Nazan ÇOBANOĞLU, Ayfer ÜLGENALP, Nerin BAHÇECİLER, Salih KAVUKÇU

DOI: 10.5606/ArchRheumatol.2017.5791

Issue: Volume 32 - Issue 1 - March 2017
6177 4771

Deteriorated Systolic Blood Pressure Recovery and Heart Rate Recovery After Graded Exercise in Children With Familial Mediterranean Fever

Havva EVRENGÜL, Selçuk YÜKSEL, Mustafa DOĞAN, Dolunay GÜRSES, Harun EVRENGÜL

DOI: 10.5606/ArchRheumatol.2017.6071

Issue: Volume 32 - Issue 3 - September 2017
4857 4294

Prognosis in Pregnant Females With Systemic Lupus Erythematosus

Enling LIU, Yuxiu ZHOU

DOI: 10.5606/ArchRheumatol.2017.6304

Issue: Volume 32 - Issue 4 - December 2017
4230 5124

The Influence of Concomitant Disorders on Disease Severity of Familial Mediterranean Fever in Children

Rabia Miray KIŞLA EKİNCİ, Sibel BALCI, Derya UFUK ALTINTAŞ, Mustafa YILMAZ

DOI: 10.5606/ArchRheumatol.2018.6488

Issue: Volume 33 - Issue 3 - September 2018
4509 4423

Effects of Familial Mediterranean Fever on Cardiac Functions in Adults: A Cross-Sectional Study Based on Speckle Tracking Echocardiography

Hilal ERKEN PAMUKCU, Mehmet DOĞAN, Cem ÖZİŞLER, Hamza SUNMAN, Melih PAMUKCU, Lale DİNÇ ASARCIKLI

DOI: 10.5606/ArchRheumatol.2019.7005

Issue: Volume 34 - Issue 2 - June 2019
1620 1705

The Role of Familial Mediterranean Fever Gene Mutation in Treatment of Infantile Colitis With Resistant Perianal Fistula

Maşallah BARAN, Yeliz ÇAĞAN APPAK, Pınar GARİPCİN, Yavuz DEMİRÇELİK, Emel Ebru PALA, Berk ÖZYILMAZ, Miray KARAKOYUN, Orkan ERGÜN

DOI: 10.5606/ArchRheumatol.2018.6741

Issue: Volume 33 - Issue 4 - December 2018
2548 1722

Disease Severity and Genotype Affect Physical Growth in Children With Familial Mediterranean Fever

Rabia Miray KIŞLA EKİNCİ, Sibel BALCI, Eray AKAY, Dilek DOĞRUEL, Derya Ufuk ALTINTAS, Mustafa YILMAZ

DOI: 10.5606/ArchRheumatol.2019.7198

Issue: Volume 34 - Issue 3 - September 2019
1755 1674

Familial Mediterranean Fever and Multiple Sclerosis Successfully Treated With Interferon Beta-1a: A Case Report

Bilgin ÖZTÜRK

DOI: 10.5606/ArchRheumatol.2019.7249

Issue: Volume 34 - Issue 4 - December 2019
1455 2180

A Child Diagnosed With Treatment-Resistant Polyarteritis Nodosa: Can the Clinical Diagnosis Be Different?

Demet ALAYGUT, Caner ALPARSLAN, Elif Perihan ÖNCEL, Fatma MUTLUBAŞ, Tunç ÖZDEMİR, Önder YAVAŞCAN, Belde KASAP DEMİR

DOI: 10.5606/ArchRheumatol.2019.7075

Issue: Volume 34 - Issue 3 - September 2019
1574 1589

Assessment of Circulating Microribonucleic Acids in Patients With Familial Mediterranean Fever

Ferhat DEMİR, Alper Han ÇEBİ, Mukaddes KALYONCU

DOI: 10.5606/ArchRheumatol.2020.7414

Issue: Volume 35 - Issue 1 - March 2020
1469 1784

The Prevalence of Familial Mediterranean Fever and Behçet’s Disease: A Cross-Sectional Study

Özgür ALPARSLAN, Buğra Han EGELİ, Yeltekin DEMİREL, Serdal UĞURLU

DOI: 10.46497/ArchRheumatol.2020.7769

Issue: Volume 35 - Issue 4 - December 2020
2495 2405

Positive effects of ocrelizumab in patients with familial mediterranean fever and coexistent multiple sclerosis

Caner Feyzi DEMİR, Ferhat BALGETiR, Özlem ETHEMOĞLU, Dürdane AKSOY, Filiz AKTAŞ, Süleyman Serdar KOCA, Mehmet Fatih YETKIN, İrem TAŞCI

DOI: 10.46497/ArchRheumatol.2021.8229

Issue: Volume 36 - Issue 2 - June 2021
1165 1518

The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients

Veli Yazısız, Vural Taner Yılmaz, İsmail Uçar, Özgür Dandin, Bengisu Aslan, Funda Erbasan, Hüseyin Koçak, Mustafa Ender Terzioğlu

DOI: 10.46497/ArchRheumatol.2021.8500

Issue: Volume 36 - Issue 3 - September 2021
1949 1803

Clinical features of children with chronic non-bacterial osteomyelitis: A multicenter retrospective case series from Turkey

Ceyhun Açarı, Elif Çomak, Şükrü Çekiç, Serkan Türkuçar, Hatice Adıgüzel Dündar, Sara Şebnem Kılıç, Sema Akman, Balahan Makay, Şevket Erbil Ünsal

DOI: 10.46497/ArchRheumatol.2021.8137

Issue: Volume 36 - Issue 3 - September 2021
1647 1584

Differentiating children with familial Mediterranean fever from other recurrent fever syndromes: The utility of new Eurofever/PRINTO classification criteria

Rabia Miray Kışla Ekinci, Sibel Balcı, Ahmet Hakan Erol, Dilek Karagöz, Derya Ufuk Altıntaş, Atıl Bisgin

DOI: 10.46497/ArchRheumatol.2021.8616

Issue: Volume 36 - Issue 4 - December 2021
1672 1464

A retrospective review of antiphospholipid syndrome from a South Asian country

Muhammad Zain Mushtaq, Syed Ahsan Ali, Zaibunnisa Sattar, Saad Bin Zafar Mahmood, Tazein Amber, Mehmood Riaz

DOI: 10.46497/ArchRheumatol.2022.8979

Issue: Volume 37 - Issue 1 - March 2022
1304 1248

Clinical study of factors associated with pregnancy outcomes in pregnant women with systemic lupus erythematosus in the southern China

Ke Zhang, Chunmei He, Qiaoting Deng, Wengen Li, Zhixiong Zhong, Jingyuan Hou

DOI: 10.46497/ArchRheumatol.2022.8870

Issue: Volume 37 - Issue 1 - March 2022
792 1499

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study

Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee

DOI: 10.46497/ArchRheumatol.2022.9140

Issue: Volume 37 - Issue 3 - September 2022
950 866

Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience

Ferhat Demir, Eda Gürler, Betül Sözeri

DOI: 10.46497/ArchRheumatol.2022.8998

Issue: Volume 37 - Issue 3 - September 2022
1217 999